We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

114 hedge funds and large institutions have $95.1M invested in Ventyx Biosciences in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $387K | Put options by funds: $126K

86% more capital invested

Capital invested by funds: $51.1M → $95.1M (+$44M)

0.02% more ownership

Funds ownership: 62.42% → 62.43% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 34

2% less funds holding

Funds holding: 116 → 114 (-2)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

Holders
114
Holders Change
-2
Holders Change %
-1.72%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
30
Reduced
41
Closed
34
Calls
$387K
Puts
$126K
Net Calls
+$261K
Net Calls Change
+$283K

Top Buyers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
+$7.33M
2
Marshall Wace
Marshall Wace
United Kingdom
+$3.87M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.68M
4
Millennium Management
Millennium Management
New York
+$1.9M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.96M
2
SCM
Sio Capital Management
New York
-$2.06M
3
State Street
State Street
Massachusetts
-$1.55M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.53M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
26
Walleye Capital
New York
$903K -$133K -82,151 -16%
QUSVM
27
Qiming U.S. Ventures Management
Washington
$882K – – –
Jane Street
28
Jane Street
New York
$857K +$568K +351,962 +724%
UBS Group
29
UBS Group
Switzerland
$786K +$93.5K +57,897 +19%
Charles Schwab
30
Charles Schwab
California
$742K -$164K -101,434 -23%
TCM
31
TCG Crossover Management
California
$677K – – –
State Street
32
State Street
Massachusetts
$613K -$1.55M -958,010 -77%
BFM
33
Boothbay Fund Management
New York
$600K -$117K -72,452 -21%
CIBC World Market
34
CIBC World Market
Ontario, Canada
$546K -$28.3K -17,500 -6%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$480K +$52.5K +32,497 +17%
IC
36
IEQ Capital
California
$411K -$3.82K -2,364 -1%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$369K -$39K -24,129 -12%
ACM
38
ADAR1 Capital Management
Texas
$361K -$183K -113,000 -40%
XT
39
XTX Topco
Cayman Islands
$346K +$182K +112,660 +230%
SPS
40
Susquehanna Portfolio Strategies
Pennsylvania
$342K +$258K +159,600 New
PFS
41
Prospera Financial Services
Texas
$319K +$241K +149,200 New
Northern Trust
42
Northern Trust
Illinois
$279K -$565K -349,859 -73%
Simplex Trading
43
Simplex Trading
Illinois
$275K +$204K +126,391 +5,029%
HighTower Advisors
44
HighTower Advisors
Illinois
$254K -$7.27K -4,500 -4%
BHCM
45
Brevan Howard Capital Management
Jersey
$246K +$185K +114,831 New
Barclays
46
Barclays
United Kingdom
$226K +$71.1K +44,034 +72%
Squarepoint
47
Squarepoint
New York
$215K +$163K +100,635 New
HF
48
HRT Financial
New York
$195K +$148K +91,434 New
JG
49
Jain Global
New York
$180K +$136K +84,200 New
Invesco
50
Invesco
Georgia
$177K -$55.6K -34,420 -29%
1
2
3 4 5

VTYX Hedge Fund Activity: Q2 2025 in Review

114 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2025, worth a combined $95.1M — up 86% from $51.1M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of VTYX and 32 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 30 added.

The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $7.33M. The largest seller was BlackRock, cutting an estimated $4.96M.

  • 114 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2025, down from 116 in Q1 2025.
  • Funds reported $95.1M of Ventyx Biosciences stock for Q2 2025, up 86% quarter-over-quarter.
  • 32 funds opened new Ventyx Biosciences positions in Q2 2025 and 34 closed out, a net change of -2 holders.
  • The largest Ventyx Biosciences buyer in Q2 2025 was Affinity Asset Advisors, an estimated $7.33M added.
  • The largest Ventyx Biosciences seller in Q2 2025 was BlackRock, an estimated $4.96M sold.

Based on aggregated 13F filings for Q2 2025.